The Defense Logistics Agency awarded a $140,200 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Olopatadine hydrochloride 0.1% eye drops. To be performed in Conshohocken, Pennsylvania from September 20-21, 2023, this order is issued against an existing DLA pharmaceuticals contract vehicle. As a leading provider of pharmaceuticals and medical supplies to the Department of Defense, DLA supports military treatment facilities worldwide in their delivery of healthcare services to active duty members and beneficiaries. Amerisourcebergen, operating from its corporate headquarters, will fulfill this requirement for the prescribed eye medication to support DLA's medical logistics mission.
Generated 12/20/23, 10:14 AM